Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review

被引:0
|
作者
Melchor, Julian [1 ]
Prajapati, Stuti [1 ]
Pichardo, Rita O. [2 ,3 ]
Feldman, Steven R. [1 ,2 ,3 ,4 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC USA
[3] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC USA
[4] Wake Forest Univ, Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA
关键词
Hidradenitis suppurativa; Cytokines; Biomarkers; Pathophysiology; Pathology; INFLAMMATION; PATHWAY; IL-10; SKIN;
D O I
10.1159/000536268
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory condition of the skin that mainly affects the apocrine gland-rich intertriginous areas. The disease manifests as painful nodules, abscesses, and pus-filled tunnels, which can severely impact patient's quality of life. While diagnosis is clinical, successful treatment options for this condition are limited. There has been an increase in research and clinical trials focusing on biomarkers and cytokines for clinical use. Understanding the potential biomarkers and cytokines implicated in HS pathogenesis may allow efficacious and safe treatment options. Summary: A literature review was conducted on nine biomarkers and cytokines. IL-1, IL-10, IL-17, IL-23, TNF-alpha, YKL-40, G-CSF, NOD2, and the complement system were identified due to their potential clinical utilization and pathophysiological involvement in HS. Key Messages: With further research expanding our understanding of the pathophysiology of HS and the roles these cytokines and biomarkers play, there is potential for utilization as diagnostic markers or development of antagonists against these specific agents for HS management.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [21] Adalimumab: A Review in Hidradenitis Suppurativa
    Kim, Esther S.
    Garnock-Jones, Karly P.
    Keam, Susan J.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2016, 17 (05) : 545 - 552
  • [22] The Microbiome in Hidradenitis Suppurativa: A Review
    Kirsty J. L. Wark
    Geoffrey D. Cains
    Dermatology and Therapy, 2021, 11 : 39 - 52
  • [23] Adalimumab: A Review in Hidradenitis Suppurativa
    Esther S. Kim
    Karly P. Garnock-Jones
    Susan J. Keam
    American Journal of Clinical Dermatology, 2016, 17 : 545 - 552
  • [24] Hidradenitis Suppurativa: Current Views on Epidemiology, Pathogenesis, and Pathophysiology
    Micheletti, Robert G.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2014, 33 : S48 - S50
  • [25] The Microbiome in Hidradenitis Suppurativa: A Review
    Wark, Kirsty J. L.
    Cains, Geoffrey D.
    DERMATOLOGY AND THERAPY, 2021, 11 (01) : 39 - 52
  • [26] Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review
    Nikolakis, Georgios
    Kaleta, Katarzyna P.
    Vaiopoulos, Aristeidis G.
    Wolter, Katja
    Baroud, Sumer
    Wojas-Pelc, Anna
    Zouboulis, Christos C.
    DERMATOLOGY, 2021, 237 (05) : 673 - 697
  • [27] Cytokine-mediated enhancement of excitotoxicity
    Hewett, SJ
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S17 - S17
  • [28] Cytokine-mediated cell survival
    Inaba, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 80 (03) : 210 - 214
  • [29] Cytokine-mediated neuronal apoptosis
    Hu, S
    Peterson, PK
    Chao, CC
    NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (4-5) : 427 - 431
  • [30] Cytokine-Mediated Cell Survival
    Toshiya Inaba
    International Journal of Hematology, 2004, 80 : 210 - 214